How does stem cell therapy treat ulcerative colitis?

MSCs modulate the overactive immune response driving UC, promote mucosal healing in the colon, reduce intestinal inflammation, and help restore the gut barrier function. This can reduce flare frequency and severity.

Can stem cell therapy achieve remission in ulcerative colitis?

MSC therapy has helped many UC patients achieve clinical remission or significant symptom reduction. Studies show improvements in endoscopic scores, reduced inflammation markers, and improved quality of life.

What UC symptoms improve with stem cell therapy?

Patients commonly report reduced abdominal pain, decreased bloody diarrhea, improved stool consistency, reduced urgency, better appetite, and increased energy levels within 1-3 months of treatment.

Stem Cell Therapy for Ulcerative Colitis: IBD Treatment Guide

How stem cell therapy may help patients with ulcerative colitis. MSC immunomodulation for IBD, HSCT outcomes for refractory UC, and the latest regenerative gastroenterology research.

Ulcerative Colitis and the Immune Reset Mechanism

Ulcerative colitis (UC) is an autoimmune inflammatory bowel disease confined to the colonic mucosa, driven by Th2 cytokine excess (IL-4, IL-5, IL-13) combined with impaired T-regulatory cell function. MSC therapy rebalances this immune dysfunction: WJ-MSCs suppress aberrant Th2 activation, expand T-regulatory cell populations, reduce mucosal pro-inflammatory cytokines (TNF-α, IL-6, IL-8), and directly promote colonic epithelial healing through secretion of epidermal growth factors. The mucosal barrier restoration effect is directly relevant to UC's defining pathology.

Evidence Base and Response Rates

Published UC case series and early trials report clinical response (Mayo score reduction ≥3 points) in 50–65% of patients and endoscopic remission in 30–45% at 12 months. Patients with moderate-to-severe UC failing first-line therapy (5-ASA, azathioprine) or intolerant to biologics show the most compelling indication. The EU approval of allogeneic MSC therapy (Alofisel®) for Crohn's perianal fistulae provides direct regulatory precedent for MSC action in IBD, supporting the plausibility of the UC mechanism.

UC Treatment Protocol in Istanbul

StemCell Longevita's UC programme delivers IV WJ-MSC infusion combined with enema-based colonic delivery to maximise mucosal contact in the affected colon segments. Pre-treatment assessment includes UCDAI/Mayo scoring, colonoscopy review, faecal calprotectin, and CRP. Treatment requires 5–7 days in Istanbul. Follow-up at 3, 6, and 12 months includes colonoscopic reassessment and faecal calprotectin monitoring coordinated with the patient's gastroenterologist.

Frequently Asked Questions

How does stem cell therapy treat ulcerative colitis?: MSCs modulate the overactive immune response driving UC, promote mucosal healing in the colon, reduce intestinal inflammation, and help restore the gut barrier function. This can reduce flare frequency and severity.
Can stem cell therapy achieve remission in ulcerative colitis?: MSC therapy has helped many UC patients achieve clinical remission or significant symptom reduction. Studies show improvements in endoscopic scores, reduced inflammation markers, and improved quality of life.
What UC symptoms improve with stem cell therapy?: Patients commonly report reduced abdominal pain, decreased bloody diarrhea, improved stool consistency, reduced urgency, better appetite, and increased energy levels within 1-3 months of treatment.

Stem Cell Therapy for Ulcerative Colitis: IBD Treatment Guide

Ulcerative Colitis and the Immune Reset Mechanism

Evidence Base and Response Rates

UC Treatment Protocol in Istanbul

Frequently Asked Questions

Transform Your Health with Regenerative Medicine in Istanbul